Search by Drug Name or NDC
NDC 36000-0324-02 Labetalol Hydrochloride 5 mg/mL Details
Labetalol Hydrochloride 5 mg/mL
Labetalol Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is LABETALOL HYDROCHLORIDE.
Product Information
NDC | 36000-0324 |
---|---|
Product ID | 36000-324_26ae2de7-7634-4eb9-8584-8f0613357778 |
Associated GPIs | 33300010102005 |
GCN Sequence Number | 005097 |
GCN Sequence Number Description | labetalol HCl VIAL 5 MG/ML INTRAVEN |
HIC3 | J7A |
HIC3 Description | ALPHA/BETA-ADRENERGIC BLOCKING AGENTS |
GCN | 18990 |
HICL Sequence Number | 002095 |
HICL Sequence Number Description | LABETALOL HCL |
Brand/Generic | Generic |
Proprietary Name | Labetalol Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Labetalol Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/mL |
Substance Name | LABETALOL HYDROCHLORIDE |
Labeler Name | Baxter Healthcare Corporation |
Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076051 |
Listing Certified Through | 2024-12-31 |
Package
NDC 36000-0324-02 (36000032402)
NDC Package Code | 36000-324-02 |
---|---|
Billing NDC | 36000032402 |
Package | 1 VIAL in 1 CARTON (36000-324-02) / 40 mL in 1 VIAL (36000-324-01) |
Marketing Start Date | 2021-01-26 |
NDC Exclude Flag | N |
Pricing Information | N/A |